Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization
机构:[1]Department of Liver Disease and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China[2]Department of Radiology, the Southwest Hospital, Third Military Medical University, Chongqing, China[3]Department of Hepatobiliary and Pancreatic Interventional Cancer, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China浙江大学医学院附属第一医院[4]Department of Minimally Invasive International Therapy, the Third Affiliated Hospital of Kunming University, Tumour Hospital of Yunnan province, Kunming, China[5]Department of Interventional Radiology, Jiangsu Provincial Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China[6]Department of Interventional Radiology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China河南省肿瘤医院[7]Department of Interventional Radiology, the Affiliated Hospital of Nantong University, Nantong, China[8]Department of Gastroenterology and Hepatology, Shandong Province Hospital Affiliated to Shandong University, Jinan, China[9]Department of Hepatobiliary Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China[10]Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, China[11]Department of Interventional Radiology, the First Affiliated Hospital of Soochow University, Suzhou, China[12]Department of Interventional Radiology, the Affiliated Tumour Hospital of Xinjiang Medical University, Urumqi, China[13]Clinical Liver Diseases Research Centre, Nanjing Military Command, 180th Hospital of PLA, Quanzhou, China[14]Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China中山大学附属第一医院[15]Interventional Medical Centre of the Affiliated Hospital of Qingdao University, Qingdao, China[16]Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Chengdu, China四川省肿瘤医院[17]Department of Interventional Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China江苏省人民医院[18]State Key laboratory of Cancer Biology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases,Fourth Military Medical University, Xi’an, China[19]Department of Health Statistics, Fourth Military Medical University, Xi'an, China
第一作者机构:[1]Department of Liver Disease and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China
通讯作者:
推荐引用方式(GB/T 7714):
Dongdong Xia,Enxin Wang,Qiuhe Wang,et al.Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization[J].JOURNAL OF HEPATOLOGY.2019,70(1):E602-E603.doi:10.1016/S0618-8278(19)31203-4.
APA:
Dongdong Xia,Enxin Wang,Qiuhe Wang,Wei Bai,Zhexuan Wang...&Guohong Han.(2019).Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization.JOURNAL OF HEPATOLOGY,70,(1)
MLA:
Dongdong Xia,et al."Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization".JOURNAL OF HEPATOLOGY 70..1(2019):E602-E603